Improving outcomes in adults with epilepsy and intellectual disability (EpAID) using a nurse-led intervention: Study protocol for a cluster randomised controlled trial

Howard Ring*, Nakita Gilbert, Roxanne Hook, Adam Platt, Christopher Smith, Fiona Irvine, Cam Donaldson, Elizabeth Jones, Joanna Kelly, Adrian Mander, Caroline Murphy, Mark Pennington, Angela Pullen, Marcus Redley, Simon Rowe, James Wason

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
152 Downloads (Pure)


Background: In adults with intellectual disability (ID) and epilepsy there are suggestions that improvements in management may follow introduction of epilepsy nurse-led care. However, this has not been tested in a definitive clinical trial and results cannot be generalised from general population studies as epilepsy tends to be more severe and to involve additional clinical comorbidities in adults with ID. This trial investigates whether nurses with expertise in epilepsy and ID, working proactively to a clinically defined role, can improve clinical and quality of life outcomes in the management of epilepsy within this population, compared to treatment as usual. The trial also aims to establish whether any perceived benefits represent good value for money. Methods/design: The EpAID clinical trial is a two-arm cluster randomised controlled trial of nurse-led epilepsy management versus treatment as usual. This trial aims to obtain follow-up data from 320 participants with ID and drug-resistant epilepsy. Participants are randomly assigned either to a 'treatment as usual' control or a 'defined epilepsy nurse role' active arm, according to the cluster site at which they are treated. The active intervention utilises the recently developed Learning Disability Epilepsy Specialist Nurse Competency Framework for adults with ID. Participants undergo 4 weeks of baseline data collection, followed by a minimum of 20 weeks intervention (novel treatment or treatment as usual), followed by 4 weeks of follow-up data collection. The primary outcome is seizure severity, including associated injuries and the level of distress manifest by the patient in the preceding 4 weeks. Secondary outcomes include cost-utility analysis, carer strain, seizure frequency and side effects. Descriptive measures include demographic and clinical descriptors of participants and clinical services in which they receive their epilepsy management. Qualitative study of clinical interactions and semi-structured interviews with clinicians and participants' carers are also undertaken. Discussion: The EpAID clinical trial is the first cluster randomised controlled trial to test possible benefits of a nurse-led intervention in adults with epilepsy and ID. This research will have important implications for ID and epilepsy services. The challenges of undertaking such a trial in this population, and the approaches to meeting these are discussed. Trial registration: International Standard Randomised Controlled Trial Number: ISRCTN96895428version 1.1. Registered on 26 March 2013.

Original languageEnglish
Article number297
Issue number1
Publication statusPublished - 24 Jun 2016


  • Clinical trial
  • Clinical trials unit
  • Cluster trial
  • Controlled trial
  • Cost-effectiveness
  • Epilepsy
  • Epilepsy nurse
  • Intellectual disability
  • Nurse-led intervention
  • Pragmatic
  • Quality of life
  • Randomised
  • Treatment
  • Treatment as usual


Dive into the research topics of 'Improving outcomes in adults with epilepsy and intellectual disability (EpAID) using a nurse-led intervention: Study protocol for a cluster randomised controlled trial'. Together they form a unique fingerprint.

Cite this